Nippon India Pharma Fund
Nippon India Pharma Fund (Direct, Growth): saplin Score 6.6/10 (Neutral) among 14 Sectoral/Thematic funds. 3Y return 18.7% a year vs 21.9% category median, expense ratio 0.98%. Better downside protection than most peers, but uneven returns. NAV ₹663.12 on 11 Nov 2026.
Loading the full analysis…